An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Overtreatment is pervasive in medicine and leads to potential patient harms and excessive costs in health care. Although evidence-based medicine is often derided as practice by rote algorithmic medicine, the appropriate application of key evidence-based medicine principles in clinical decision making is fundamental to preventing overtreatment and promoting high-value, individualized patient-centered care. Specifically, this article discusses the importance of (1) using absolute rather than relative estimates of benefits to inform treatment decisions; (2) considering the time horizon to benefit of treatments; (3) balancing potential harms and benefits; and (4) using shared decision making by physicians to incorporate the patient's values and preferences into treatment decisions. Here, we illustrate the application of these principles to considering the decision of whether or not to recommend intensive glycemic control to patients to minimize microvascular and cardiovascular complications in type 2 diabetes mellitus. Through this lens, this example will illustrate how an evidence-based medicine approach can be used to individualize glycemic goals and prevent overtreatment, and can serve as a template for applying evidence-based medicine to inform treatment decisions for other conditions to optimize health and individualize patient care.

Original languageEnglish (US)
Pages (from-to)180-195
Number of pages16
JournalCirculation
Volume135
Issue number2
DOIs
StatePublished - Jan 10 2017

Fingerprint

Evidence-Based Medicine
Hypoglycemic Agents
Diabetes Mellitus
Medicine
Patient Harm
Patient-Centered Care
Patient Preference
Therapeutics
Health Care Costs
Type 2 Diabetes Mellitus
Lenses
Decision Making
Patient Care
Physicians
Medical Overuse
Health

Keywords

  • Clinical decision making
  • Diabetes complications
  • Diabetes mellitus
  • Evidence-based medicine
  • Medical overuse
  • Review

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

@article{84a75b288bd34cd0a026adefaf2f929b,
title = "An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment",
abstract = "Overtreatment is pervasive in medicine and leads to potential patient harms and excessive costs in health care. Although evidence-based medicine is often derided as practice by rote algorithmic medicine, the appropriate application of key evidence-based medicine principles in clinical decision making is fundamental to preventing overtreatment and promoting high-value, individualized patient-centered care. Specifically, this article discusses the importance of (1) using absolute rather than relative estimates of benefits to inform treatment decisions; (2) considering the time horizon to benefit of treatments; (3) balancing potential harms and benefits; and (4) using shared decision making by physicians to incorporate the patient's values and preferences into treatment decisions. Here, we illustrate the application of these principles to considering the decision of whether or not to recommend intensive glycemic control to patients to minimize microvascular and cardiovascular complications in type 2 diabetes mellitus. Through this lens, this example will illustrate how an evidence-based medicine approach can be used to individualize glycemic goals and prevent overtreatment, and can serve as a template for applying evidence-based medicine to inform treatment decisions for other conditions to optimize health and individualize patient care.",
keywords = "Clinical decision making, Diabetes complications, Diabetes mellitus, Evidence-based medicine, Medical overuse, Review",
author = "Makam, {Anil N.} and Nguyen, {Oanh K.}",
year = "2017",
month = "1",
day = "10",
doi = "10.1161/CIRCULATIONAHA.116.022622",
language = "English (US)",
volume = "135",
pages = "180--195",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment

AU - Makam, Anil N.

AU - Nguyen, Oanh K.

PY - 2017/1/10

Y1 - 2017/1/10

N2 - Overtreatment is pervasive in medicine and leads to potential patient harms and excessive costs in health care. Although evidence-based medicine is often derided as practice by rote algorithmic medicine, the appropriate application of key evidence-based medicine principles in clinical decision making is fundamental to preventing overtreatment and promoting high-value, individualized patient-centered care. Specifically, this article discusses the importance of (1) using absolute rather than relative estimates of benefits to inform treatment decisions; (2) considering the time horizon to benefit of treatments; (3) balancing potential harms and benefits; and (4) using shared decision making by physicians to incorporate the patient's values and preferences into treatment decisions. Here, we illustrate the application of these principles to considering the decision of whether or not to recommend intensive glycemic control to patients to minimize microvascular and cardiovascular complications in type 2 diabetes mellitus. Through this lens, this example will illustrate how an evidence-based medicine approach can be used to individualize glycemic goals and prevent overtreatment, and can serve as a template for applying evidence-based medicine to inform treatment decisions for other conditions to optimize health and individualize patient care.

AB - Overtreatment is pervasive in medicine and leads to potential patient harms and excessive costs in health care. Although evidence-based medicine is often derided as practice by rote algorithmic medicine, the appropriate application of key evidence-based medicine principles in clinical decision making is fundamental to preventing overtreatment and promoting high-value, individualized patient-centered care. Specifically, this article discusses the importance of (1) using absolute rather than relative estimates of benefits to inform treatment decisions; (2) considering the time horizon to benefit of treatments; (3) balancing potential harms and benefits; and (4) using shared decision making by physicians to incorporate the patient's values and preferences into treatment decisions. Here, we illustrate the application of these principles to considering the decision of whether or not to recommend intensive glycemic control to patients to minimize microvascular and cardiovascular complications in type 2 diabetes mellitus. Through this lens, this example will illustrate how an evidence-based medicine approach can be used to individualize glycemic goals and prevent overtreatment, and can serve as a template for applying evidence-based medicine to inform treatment decisions for other conditions to optimize health and individualize patient care.

KW - Clinical decision making

KW - Diabetes complications

KW - Diabetes mellitus

KW - Evidence-based medicine

KW - Medical overuse

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=85009239913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009239913&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.116.022622

DO - 10.1161/CIRCULATIONAHA.116.022622

M3 - Article

VL - 135

SP - 180

EP - 195

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -